NISA INVESTMENT ADVISORS, LLC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$11,549
-10.9%
4520.0%0.00%
Q2 2023$12,963
+259160.0%
452
+126.0%
0.00%
Q1 2023$5
+66.7%
2000.0%0.00%
Q4 2022$3
-99.9%
2000.0%0.00%
Q3 2022$4,000
+33.3%
2000.0%0.00%
Q2 2022$3,000
-40.0%
2000.0%0.00%
Q1 2022$5,000
-83.3%
200
-82.6%
0.00%
Q4 2021$30,000
-47.4%
1,150
-4.2%
0.00%
Q3 2021$57,000
+39.0%
1,2000.0%0.00%
Q2 2021$41,0000.0%1,200
+20.0%
0.00%
Q1 2021$41,000
-4.7%
1,0000.0%0.00%
Q4 2020$43,0001,0000.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders